2342 · TRANS GENIC GROUP INC. · Financials
Market Cap
3.38B JPY
Shares
16.65M
Volume · Nov 13
159.9K
Avg daily vol (3M)
51.1K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.
Revenue
13.17B
+1.3%
FY2026
Net Income
-77.27M
+92.9%
FY2026
Gross Margin
18.47%
+1.8pp
FY2026
Operating Margin
1.05%
+3pp
FY2026
Operating Cash Flow
25.91M
-72.5%
FY2026
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| JPY | 13.17B | 13.01B | 13.08B | 11.43B | 12.58B |
| JPY | 10.74B | 10.84B | 10.83B | 9.43B | 8.74B |
| JPY | 2.43B | 2.17B | 2.25B | 1.99B | 3.84B |
| JPY | 137.96M | -259.51M | 89.44M | -25.15M | 1.84B |
| JPY | -207.44M | -675.96M | 43.08M | -331.81M | 2.77B |
| JPY | -109.98M | 414.6M | 39.09M | 108.09M | 907.68M |
| JPY | -77.27M | -1.09B | 4.09M | -409.67M | 1.88B |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2022–FY2026: 286.56M in dividends.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.